纤溶酶原激活物抑制因子1(PAI1)真核蛋白
Eukaryotic Plasminogen Activator Inhibitor 1 (PAI1)
SERPINE1; PLANH1; Serpin Peptidase Inhibitor Clade E Member 1; Nexin,Plasminogen Activator Inhibitor Type 1 Serpin E1; Endothelial plasminogen activator inhibitor
- 编号EPA532Hu61
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源真核表达
- 宿主293F Cell
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量44.4kDa
- 实际分子量46kDa(差异分析请参阅说明书)
- 片段与标签Val24~Pro402 with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 5% Trehalose.
- 性状冻干粉
- 纯度> 95%
- 等电点7.5
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1368 ¥ 3420 ¥ 6840 ¥ 20520 ¥ 51300
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPA532Hu02 | 纤溶酶原激活物抑制因子1(PAI1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA532Hu61 | 纤溶酶原激活物抑制因子1(PAI1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA532Hu01 | 纤溶酶原激活物抑制因子1(PAI1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA532Hu61 | 纤溶酶原激活物抑制因子1(PAI1)活性蛋白 | Cell culture; Activity Assays. |
PAA532Hu01 | 纤溶酶原激活物抑制因子1(PAI1)多克隆抗体 | WB; IHC; ICC; IP. |
PAA532Hu02 | 纤溶酶原激活物抑制因子1(PAI1)多克隆抗体 | WB; IHC; ICC; IP. |
LAA532Hu71 | 纤溶酶原激活物抑制因子1(PAI1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
LAA532Hu81 | 纤溶酶原激活物抑制因子1(PAI1)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
MAA532Hu22 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC/IF |
MAA532Hu24 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu27 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu29 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu25 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu21 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu26 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC; ICC; IP. |
MAA532Hu23 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | WB; IHC |
FAA532Hu04 | 抗纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | Flow cytometry. |
FAA532Hu02 | 抗纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | Flow cytometry. |
FAA532Hu06 | 抗纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | Flow cytometry. |
FAA532Hu08 | 抗纤溶酶原激活物抑制因子1(PAI1)单克隆抗体 | Flow cytometry. |
LAA532Hu74 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体(生物素标记) | WB; IHC; ICC. |
LAA532Hu76 | 纤溶酶原激活物抑制因子1(PAI1)单克隆抗体(生物素标记) | WB; IHC; ICC. |
MEA532Hu | 纤溶酶原激活物抑制因子1(PAI1)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEA532Hu | 纤溶酶原激活物抑制因子1(PAI1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA532Hu | 纤溶酶原激活物抑制因子1(PAI1)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA532Hu | 纤溶酶原激活物抑制因子1(PAI1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
PSA532Hu01 | 纤溶酶原激活物抑制因子1(PAI1)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA532Hu01 | 纤溶酶原激活物抑制因子1(PAI1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Breast Cancer Research and Treatment | Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice [SpringerLink: f3w831267267p277] |
Clin Appl Thromb Hemost. | Is There Any Association Between Thrombosis and Tissue Factor Pathway Inhibitor Levels in Patients With Vitamin D Deficiency? [Pubmed: 24203351] |
Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502] |
Archives of Physiology and Biochemistry | Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder [Pubmed:26934364] |
Naunyn-Schmiedeberg's Archives of Pharmacology | Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression [pubmed:27447455] |
Environmental toxicology and pharmacology | Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats. [pubmed:28376377] |
Annals of Clinical & Laboratory Science | Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment [pubmed:28249913] |
Pharmacological reports | Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent [pubmed:28349880] |
Haematologica | Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain [Pubmed:29903766] |
Biomedicine & Pharmacotherapy | Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells [Pubmed:29775893] |
Archives of Physical Medicine and Rehabilitation | Impact of Regular Physical Activity on Adipocytokines and Cardiovascular Characteristics in Spinal Cord–Injured Subjects [Pubmed:29548578] |
Marine Drugs | Anticoagulant and Antithrombotic Properties in Vitro and in Vivo of a Novel Sulfated Polysaccharide from Marine Green Alga Monostroma nitidum [Pubmed: 31027312] |
Experimental and Therapeutic Medicine | IKKβ regulates the expression of coagulation and fibrinolysis factors through the NF‑κB canonical pathway in LPS‑stimulated alveolar epithelial cells type II [Pubmed: 31572531] |
Phytomedicine | Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway [Pubmed: 32120245] |
Sci Rep | Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis [Pubmed:35013379] |
Phytomedicine | Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug … [Pubmed:35121390] |
留言咨询